BD
A comprehensive, multi-solution Financial Value Assessments (one for U.S. and one for Canada) for BD’s Alaris, Pyxis, and HealthSight solutions.
BD
Kate Edwards, Director, Sales
“By using the FVA, I can show my prospects how our solution not only provides the outlined benefits, but it also how it pays for itself in the first year – and can confidently say this “IS” their solution.”
Healthymyne
Neal Miller, Vice President of Marketing, HealthMyne
“The FVA model is extremely easy to use and having integrated PowerPoints make fast work of producing presentations of the data for our customers. Having this available has definitely helped close deals!”
Sunquest
Hannah Timms-Cremeans, Strategic Account Executive, Sunquest
“The FVA tool also allows the key buyer to present these findings in a meaningful manner to the C-suite as they are always looking for hard facts before making a buying decision. No contract is concluded without checking all the boxes and the FVA does this.”
Pipeline Rx
Chuck Dunlop, Executive Vice President - Customer Development & Experience, Pipeline Rx
“The FHG team is professional and thoroughly understands how technologies impact the bottom line. In this ever challenging healthcare environment, with shrinking reimbursement rates and rising costs, this is critical for the health of the clients we serve. “
Change Healthcare
Itai Galili, Director of Product Management, Change Healthcare
“The customers were impressed with the level of detail and the thorough approach we can now take when looking at possible benefits they might experience. Showing the benefits in conjunction with the cost and cost avoidance is helping with the budget justification and internal bought in on the customer side.”
Change Healthcare
Ran Rumianek, Senior Director, Enterprise Workflow Solutions. Change Healthcare
“The FVA tool was very helpful in establishing a value based discussions with our customers rather than get into the usual feature comparisons. The customers were impressed by our understanding of the value realization to the hospital and patients rather than to the end user. We also found it helpful in enabling our customers to…
Our Work
American Cancer Society (ACS)
Distributed by the National Lung Cancer Round Table (NLCRT), FHG created a financial forecasting tool to assist in understanding the financial impact of the implementation and expansion of high quality lung cancer screening and pulmonary nodule evaluation programs.
Mount Sinai
A custom analysis of the financial benefit opportunity of standardizing disparate EHRs on a single EHR platform.
Change Healthcare
A Financial Value Assessment for automating Radiology workflows with their Workflow Intelligence solution and an automated questionnaire for Cardiology and Radiology assessments.
Go2 Foundation
A custom model that quantifies the positive financial value for hospitals starting or expanding a current Lung Cancer Screening program.
Sutter Health
A custom analysis of the financial benefit opportunity of implementing Epic’s EHR across the system.
TigerConnect
A Financial Value Assessment for TigerConnect’s solutions to support better communication among clinical providers, payers, and patients.
Terumo BCT
Consulting Services to provide overview of healthcare changes in the United States, financial reimbursement impact, and generating financial value within Blood Services and Management marketplace.
Orion Health
Two Financial Value Assessments, one for Payors and one for Providers, focusing on Orion’s financial value of Population Health Management software in both Fee-for-Service and Value-based Care reimbursement environments.
BCG Digital Ventures
BCG contracted with FHG to develop a Financial Value Assessment for a BCG Digital Ventures partner company.
National Lung Cancer Roundtable (NLCRT)
Distributed by NLCRT, FHG created a financial forecasting tool to assist in understanding the financial impact of the implementation and expansion of high quality lung cancer screening and pulmonary nodule evaluation programs
Impact Advisors
Provided consulting services to evaluate the financial benefit opportunities for health system EHR implementations.
Quest Diagnostics
A Financial Value Assessment for Quest Diagnostics’ Care360 EHR and Care360 Data Exchange solutions.
CareFusion
A series of individual Financial Value Assessments for their solutions, including; Asset Management, Charge Capture, EMR Interoperability, Infusion Viewer, Knowledge Portal, and PCA Pause.
PipelineRx
A Financial Value Assessment to demonstrate the pharmacy labor impact by using PipelineRx’s telepharmacy services and software platform.
The HCI Group
Provided Consulting Services to evaluate the financial benefit opportunities for health system EHR implementations.
Truven Health
A Financial Value Assessment for Truven’s Micromedex 360 Care Insights Suite.
HealthMyne
A Financial value assessment for HealthMyne’s Cancer Screening, Incidental Findings, Tumor Conference and Therapy Response modules, modeling the financial ROI and showing impact of Fee-for-Service and Value-based Care reimbursement models.
SCI Solutions
A Financial Value Assessment for SCI’s scheduling solutions, Schedule Maximizer and Order Facilitator, as well as several custom engagements with different SCI customers.
Verge Health
A Financial Value Assessment for Verge’s Converge Platform, including modules for Accreditation & Regulatory, Claims, Credentialing, Event Management, Patient Relations, and Peer Review as well as a post-live assesment with a key Verge customer.
Taylor Healthcare
A Financial Value Assessment for Taylor’s (then Standard Register) DCIA, FDMS, and FOD solutions.